Purple Biotech Announces Pricing of Up To $18 Million Public Offering
Purple Biotech Announces Pricing of Up To $18 Million Public Offering GlobeNewswire September 04, 2025 $6 million upfront with up to an additional $12 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants REHOVOT, Israel, Sept. 04, 2025 (GLOBE NEWSWIRE) — Purple Biotech Ltd. (“Purple Biotech” or “the Company”) (NASDAQ/TASE: […]